Physician profile
James E Jones
NPI 1407960586
$134,008.55
in general payments reported to CMS, 2019-2025
29 companies · $570 in 2025
The $570 reported for 2025 was more than what 83% of Obstetrics & Gynecology providers received nationally (typical 2025 total: $158).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $72K · 2020: $23K · 2021: $17K · 2022: $13K · 2023: $7,362 · 2024: $327 · 2025: $570.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program: $5,600 · Food and Beverage: $1,541 · Travel and Lodging: $1,002 · Education: $109 · Gift: $6.24.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program | $5,600.00 |
| Food and Beverage | $1,541.46 |
| Travel and Lodging | $1,001.66 |
| Education | $109.32 |
| Gift | $6.24 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $120,659.39 | 2019-2023 | |
| Sumitomo Pharma America, INC. | $7,034.68 | 2023-2025 | Myfembree |
| Myovant Sciences INC. | $3,905.60 | 2021-2022 | |
| Ascend Therapeutics US, LLC | $540.85 | 2022-2024 | |
| Astellas Pharma US INC | $462.20 | 2023-2025 | Veozah |
| Therapeuticsmd, INC. | $232.43 | 2019-2022 | |
| Pfizer INC. | $206.46 | 2019-2024 | |
| Organon LLC | $200.83 | 2021-2025 | |
| Mayne Pharma Commercial LLC | $174.32 | 2021-2024 | |
| Hologic Sales and Service, LLC | $75.22 | 2019-2022 | |
| Avion Pharmaceuticals | $72.63 | 2019-2021 | |
| Lilly USA, LLC | $47.36 | 2025 | Zepbound |
| Lupin INC. | $40.36 | 2019-2021 | |
| Millicent US INC | $40.26 | 2025 | Intrarosa, Femring, Femlyv |
| Merck Sharp & Dohme LLC | $36.68 | 2019 |
Show all 29 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Coopersurgical, INC. | $33.23 | 2019-2020 | |
| Mylan Pharmaceuticals INC. | $26.72 | 2019 | |
| Allergan, INC. | $26.27 | 2019-2020 | |
| Exeltis, USA INC. | $25.44 | 2019-2020 | |
| Duchesnay USA Incorporated | $24.91 | 2019 | |
| Vertical Pharmaceuticals, LLC | $20.22 | 2019 | |
| Bayer Healthcare Pharmaceuticals INC. | $19.89 | 2025 | |
| Amag Pharmaceuticals, INC. | $17.95 | 2019 | |
| Exact Sciences Corporation | $16.65 | 2025 | Cologuard Collection Kit |
| Novo Nordisk INC | $15.79 | 2023 | |
| Minerva Surgical, INC | $14.14 | 2023 | |
| Ethicon US, LLC | $13.11 | 2022 | |
| Agile Therapeutics, INC. | $13.09 | 2021 | |
| Covidien Lp | $11.87 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw James Jones listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.